Innovation in Health has opened 8 open innovation challenges in cooperation with Abbott, Aidian, Takeda, Beurer, GSK, Qiagen, Siemens Healthineers and 4 hospitals affiliated with University of Medicine and Pharmacy “Grigore T. Popa”.

Eight challenges across three programmes are open to companies whose product/technology matches the challenges released. Participation does not anticipate equity or IP involvement. Selected companies will participate in a 4-module structured process, including one-to-one pitch training and partnership exploration meetings.

It is a unique opportunity to have direct contact with industry leaders and healthcare providers — applications are open until 16 April 2023!